Evaluation of the Safety and Efficacy of Ketotifen 4.0% Patch as Compared to Placebo Patch, Olopatadine 0.2% Ophthalmic Solution, and Artificial Tears in the Conjunctival Allergen Challenge (CAC) Model of Acute Allergic Conjunctivitis
Clinical trial NCT00836485 · COMPLETED
Trial details
- NCT number
- NCT00836485
- Sponsor
- Senju USA, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-02-01
- Primary completion
- 2009-03-01
- Enrollment
- 122
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.